Biopharmaceuticals
Accentia Biopharmaceuticals Announces that Revimmune is Profiled in Hopkins Medicine Magazine
Published in Blood Weekly, February 14th, 2008
The article, titled, "High Time for HiCy" chronicles the history of the development of Revimmune (high-dose cyclophosphamide or HiCy). Elaine Freeman reports on studies conducted by Johns Hopkins University researchers using Revimmune which show remarkable promise, as well as durable remissions and potential cures for autoimmune diseases, such as multiple sclerosis, myasthenia gravis, scleroderma, severe aplastic anemia, and lupus.
To...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2008-02-14)
More Articles from Blood Weekly
- Acute Lymphoblastic Leukemia
Studies from E. Tavernier and colleagues provide new data on acute lymphoblastic leukemia - Amgen Inc.
Pooled Phase 3 Study of Nplate(TM) (Romiplostim) in Adult Patients with Chronic ITP Published in the Lancet - Angiotensins
Recent findings from University of Texas highlight research in angiotensins - Aortic Dissection
Study data from P. Bergeron and colleagues update understanding of aortic dissection - Cancer
Research on cancer discussed by T.W. Kim and co-researchers - Clinical Trial Research
M's Science Corporation Initiated European Phase 2 Study in Stroke Recovery - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
